Skip to main content
Clinical Trials/CTRI/2018/01/011131
CTRI/2018/01/011131
Completed
未知

A Prospective Observational study to assess the cardiotoxicity induced by tyrosine kinase inhibitors in a tertiary care hospital

Koilagundla Niranjan0 sites80 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Cancer Patients
Sponsor
Koilagundla Niranjan
Enrollment
80
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 14, 2017
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Koilagundla Niranjan

Eligibility Criteria

Inclusion Criteria

  • 1 Age 18 to 60 years of either gender
  • 2 Subjects who will be undergoing therapy with tyrosine kinase inhibitors for various cancers
  • 3 those who are willing to give informed consent
  • 4 those who are willing to follow study related procedures

Exclusion Criteria

  • 1 History of cardiovascular diseases
  • 2 history of intake of other concomitant cardiotoxic drugs
  • 3 Pregnant and lactating females
  • 4 History of secondary or previous history of any other malignancies

Outcomes

Primary Outcomes

Not specified

Similar Trials